S&N’s Potential Biomet Acquisition Would Create Top-Tier Ortho Player
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew is weighing a potential acquisition of Biomet that would create a top-tier reconstructive orthopedic implant player and tighten competition with rivals Zimmer, Stryker and Johnson & Johnson/DePuy